Altered expression of DNA-topoisomerase IIα is associated with increased rate of spontaneous polyploidization in etoposide resistant K562 cells

被引：11

作者：

Melixetian, MB ^{[1
]}

Beryozkina, EV ^{[1
]}

Pavlenko, MA ^{[1
]}

Grinchuk, TM ^{[1
]}

机构：

[1] Russian Acad Sci, Inst Cytol, St Petersburg 194064, Russia

来源：

LEUKEMIA RESEARCH | 2000年 / 24卷 / 10期

基金：

俄罗斯基础研究基金会;

关键词：

etoposide resistance; bcl-2 family genes; topoisomerase II; polyploidization; K562; cells;

D O I：

10.1016/S0145-2126(00)00054-0

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Molecular mechanisms of drug resistance and alterations in chromosome number were studied in two independently etoposide selected clonal cell lines, K562-VP16-1 and K562-W16-2, and in bulk cell line K562-VP16. In all cell lines was observed down-regulation of topo II alpha gene expression, while topo II beta mRNA content was unchanged compared to parental cell line. Antiapoptotic bcl-2 mRNA content was decreased in all drug resistant cell variants, the level of bcl-X-L mRNA was greatly diminished only in one of cell lines, K562-VP16-1. Proapoptotic bax mRNA was down regulated to an undetectable level in all resistant cell lines analysed. These data indicate that abrogation of bax-mediated apoptosis can be implicated in development of etoposide resisance. Cytogenetic analysis revealed increased rate of spontaneous polyploidization in K562-VP16 bulk and K562-VP-16-2 cells, while in K562-VP-16-1 cells was observed only moderate accumulation of polyploid cells. The degree of changes in topo IIa but not bcl-2 family members expression correlated positively with dynamics of accumulation of polyploid cells. Our findings suggest that down regulation of topo II alpha in association with p53 deficiency can confer chromosomal instability in etoposide-resistant K562 cells. (C) 2000 Elsevier Science Ltd. All rights reserved.

引用

页码：831 / 837

页数：7

共 35 条

[31]

TSURUO T, 1986, JPN J CANCER RES, V77, P682

[32]

VANDERZEE AGJ, 1994, CANCER RES, V54, P749

[33] POLYPLOIDY INDUCTION AS A CONSEQUENCE OF TOPOISOMERASE INHIBITION - A FLOW CYTOMETRIC ASSESSMENT [J].

ZUCKER, RM ;

ADAMS, DJ ;

BAIR, KW ;

ELSTEIN, KH .

BIOCHEMICAL PHARMACOLOGY, 1991, 42 (11) :2199-2208

[34]

ZWELLING LA, 1989, J BIOL CHEM, V264, P16411

[35] CROSS-RESISTANCE OF AN AMSACRINE-RESISTANT HUMAN LEUKEMIA LINE TO TOPOISOMERASE-II REACTIVE DNA INTERCALATING AGENTS - EVIDENCE FOR 2 TOPOISOMERASE-II DIRECTED DRUG ACTIONS [J].

ZWELLING, LA ;

MAYES, J ;

HINDS, M ;

CHAN, D ;

ALTSCHULER, E ;

CARROLL, B ;

PARKER, E ;

DEISSEROTH, K ;

RADCLIFFE, A ;

SELIGMAN, M ;

LI, L ;

FARQUHAR, D .

BIOCHEMISTRY, 1991, 30 (16) :4048-4055

← 1 2 3 4 →